Progress in Experimental Tumor Research 4. [antikvár]

Editor's Foreword Many favorable reviews from eight countries and unusually large numbers of reprint requests received by our contributors document the excellent reception received by the three previous volumes of this series and demonstrate that Progress in Experimental Tumor Research renders a useful service to the cancer research community. Selection of the contents of Volume IV was again guided, to some extent, by responses of cancer researchers to a questionnaire (see Volume I). There appears to be developing a growing awareness regarding the importance of the early phases of cancer induction and regarding the population dynamics of malignant cells. This problem is treated from various angles in the first four chapters, which are grouped under the heading of Progress in Carcinogenesis. The malignant cell encounters many host reactions and, in turn, adapts to these. Such phenomena are discussed in the chapters grouped under Progress in Studies on Tumor-host Relationships. In the field of virology, the most intriguing recent advance appears to be the discovery of oncogenic viruses in monkey tissues employed for culture and the production of vaccines. This is covered in the chapter on Progress in Virology. The fifth volume, to follow in 1964, will expand some of the past and current contributions. Thus, W. E. Poel (Pittsburgh, Pa.), K. Set Ala (Helsinki, Finland), F. Bischoff (Santa Barbara, Cal.), B. A. Rubin (Philadelphia, Pa.), T. L. Dao (Buffalo, N.Y.) and F. J. C. Roe (London, England) will discuss some aspects of carcinogenesis: J. D. Almeida (Ontario, Canada) and A. A. Axel-rad (Toronto, Canada) will discuss morphologic properties of viruses, and C. M. Martin (Jersey City, N.J.) will write on carcinogens and viruses, while C. Maltoni (Bologna, Italy) and H. O. Sjogren (Stockholm, Sweden) will discuss certain host reactions: and J. F. Henderson (Alberta, Canada) and A. C. Sartorelli (New Haven, Conn.) will be concerned with mechanisms of action of anticancer compounds. Progress in Experimental Tumor Research now appears to flow in certain rather well-defined directions which are reported on in the